Qualcomm, Aptiv, Palo Alto And A Health Care Stock On CNBC's 'Final Trades' - AbbVie (NYSE:ABBV), Aptiv (NYSE:APTV)

On CNBC's “Halftime Report Final Trades” on Tuesday, Jason Snipe, founder and chief investment officer of Odyssey Capital Advisors, said he is staying long on AbbVie Inc. (NYSE:ABBV).Supporting his view, Guggenheim analyst Vamil Divan maintained an AbbVie Buy rating on Oct. 20, raising the price target from $227 to $242.Jim Lebenthal, partner at Cerity Partners, picked QUALCOMM Incorporated (NASDAQ:QCOM) as his final trade.According to recent news, Satellite communications company Iridium Communications (NA ...